MedPath

University Of Maryland, Baltimore

University Of Maryland, Baltimore logo
🇺🇸United States
Ownership
-
Established
1807-01-01
Employees
7.3K
Market Cap
-
Website
http://www.umaryland.edu

Clinical Trials

651

Active:29
Completed:352

Trial Phases

6 Phases

Early Phase 1:28
Phase 1:62
Phase 2:96
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (568 trials with phase data)• Click on a phase to view related trials

Not Applicable
293 (51.6%)
Phase 2
96 (16.9%)
Phase 4
76 (13.4%)
Phase 1
62 (10.9%)
Early Phase 1
28 (4.9%)
Phase 3
13 (2.3%)

Pre-Incision Peripheral Nerve Blocks for Lower Extremity Fracture Surgery in Older Adults

Not Applicable
Not yet recruiting
Conditions
Lower Extremity Fracture
Surgical Fracture Repair
Orthopaedic Trauma
Orthogeriatric Fractures
Interventions
Drug: Local anesthesia injections
First Posted Date
2025-10-16
Last Posted Date
2025-10-16
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
34
Registration Number
NCT07217626
Locations
🇺🇸

University of Maryland, Baltimore, Maryland, United States

Split-Mouth Comparison of Invisalign Attachments

Not Applicable
Not yet recruiting
Conditions
Wear, Restoration
Volume Assessment
Clear Aligner Appliance
First Posted Date
2025-10-10
Last Posted Date
2025-10-10
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
30
Registration Number
NCT07215598
Locations
🇺🇸

University of Maryland School of Dentistry, Baltimore, Maryland, United States

Preserving Ability Through Virtual Exercise (PAVE)

Not Applicable
Not yet recruiting
Conditions
Feasibility Studies
First Posted Date
2025-09-23
Last Posted Date
2025-09-23
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
140
Registration Number
NCT07189286
Locations
🇺🇸

UMMC Midtown Campus, Baltimore, Maryland, United States

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

Not Applicable
Conditions
B-Cell Lymphoma
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Richter Transformation
Diffuse Large B Cell Lymphoma (DLBCL)
Follicular Lymphoma
Transformed Follicular Lymphoma (tFL)
Primary Mediastinal Large B-cell Lymphoma (PMBCL)
Mantle Cell Lymphoma
Marginal Zone Lymphoma
Interventions
Biological: CD19.20.22 CAR T cells
First Posted Date
2025-09-11
Last Posted Date
2025-09-11
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
15
Registration Number
NCT07168486
Locations
🇺🇸

University of Maryland, Baltimore, Baltimore, Maryland, United States

Older Adults, Methadone, and Cognitive Function

Not Applicable
Not yet recruiting
Conditions
Opioid Use Disorder
Cognitive Ability General
First Posted Date
2025-09-03
Last Posted Date
2025-09-12
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
20
Registration Number
NCT07153029
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 131
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.